Last Updated on October 17, 2024 by The Health Master
The Drugs Controller General of India (DCGI) has given an emergency use approval to the single-dose C-19 vaccine Sputnik Light, Union health minister Mansukh Mandaviya tweeted.
Mandaviya also said that the addition of the vaccine will boost the country’s fight against the C-19 pandemic.
“DCGI has granted emergency use permission to Single-dose Sputnik Light C-19 vaccine in India,” he said.
“This is the 9th #C-19 vaccine in the country. This will further strengthen the nation’s collective fight against the pandemic,” he added.
Sputnik V’s two-dose regimen has already been approved in India back in April 2021.
With the approval in India, more than 2.5 billion people globally could access Sputnik Light as a one-dose vaccine and “universal booster”, the Russian Direct Investment Fund (RDIF) said.
“Thus, Sputnik Light has been registered in more than 30 countries with a total population of over 2.5 billion people.
A number of countries, including Argentina, Bahrain, UAE, San Marino and Philippines, have already authorized Sputnik Light as a universal booster,” the RDIF said following the approval in India.
Dr Reddy’s Laboratories, which the RDIF called its major partner in the country.
“Positive data from these trials have been presented to India’s regulator and contributed to the positive decision by DCGI,” the RDIF said.
“Sputnik Light will add to India’s national vaccine portfolio and join Sputnik V, which was approved in the country in April 2021. India is the leading production hub for Sputnik V,” it added.
The DCGI’s nod for an emergency use approval to Sputnik Light came on the day the country’s C-19 vaccination drive administered more than 169.46 crore doses as of 7 am on the day, the Union ministry of health and family welfare said on Sunday.
Data from the ministry showed that it also included the 14,727,674 precautionary third doses.
Proposal submitted to DCGI to test Sputnik Light as booster dose: Dr Reddy’s
Isopropyl Alcohol IP will uplift the prestige of the Pharma sector
CSIR bone health drug to be developed in US
Govt to include Acitretin in Schedule H of Drugs Rules, 1945
DoP revises list of Medical Devices for which no local manufacturers…
Stop use of Kanamycin injection: TB activists
IPC to develop & revise IP general chapters, Monographs
USFDA gives nod to Granules India for generic antidepressant drug
NPPA extends trade margin capping on these 5 Medical Devices
Latest Notifications regarding Pharmaceuticals
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
